title: Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group.
abstract: The genetic factors that underlie idiopathic dilated cardiomyopathy (IDCM) have not yet been elucidated. Since beta1-adrenoceptors are downregulated in patients with IDCM, and since beta-blocker therapy is consistently beneficial in this setting, we hypothesized that genetic variation in the beta1-adrenoceptor might affect susceptibility to and/or severity of IDCM. As no intragenic polymorphism was available, a systematic screening of the gene was first performed. The organization and sequence of the human beta1-adrenoceptor gene were established using polymerase chain reaction, single-strand conformation polymorphism analysis and sequencing. The gene comprises 1434 bp and no intron was observed. We found a unique and frequent polymorphism (C1165G) which predicts an Arg389Gly substitution. The association of this polymorphism with IDCM was then analysed using the PCR-restriction fragment length polymorphism method in the CARDIGENE population, a clinically well-characterized population of IDCM. Genotypic distribution was in agreement with Hardy-Weinberg equilibrium. There were no differences in the beta1-adrenoceptor allele frequencies between IDCM (n=426; C/G=0.76/0.24) and age- and sex-matched control subjects (n=395; C/G=0.78/0.22). Within the patient group, no association was observed with the severity of the disease. In conclusion, the genomic organization of beta1-adrenoceptor is described here for the first time. We found a unique and frequent polymorphism in the coding sequence of the gene. No association was observed between IDCM and the genetic variant. Its possible involvement in other cardiac diseases related to the beta1-adrenoceptor remains to be analysed.
authors.affiliation: Laboratoire de Génétique et Insuffisance Cardiaque, Université Paris VI/Association Claude Bernard, France.
authors.forename: F
authors.initials: F
authors.lastname: Tesson
authors.forename: P
authors.initials: P
authors.lastname: Charron
authors.forename: M
authors.initials: M
authors.lastname: Peuchmaurd
authors.forename: V
authors.initials: V
authors.lastname: Nicaud
authors.forename: F
authors.initials: F
authors.lastname: Cambien
authors.forename: L
authors.initials: L
authors.lastname: Tiret
authors.forename: O
authors.initials: O
authors.lastname: Poirier
authors.forename: M
authors.initials: M
authors.lastname: Desnos
authors.forename: Y
authors.initials: Y
authors.lastname: Jullières
authors.forename: P
authors.initials: P
authors.lastname: Amouyel
authors.forename: G
authors.initials: G
authors.lastname: Roizès
authors.forename: R
authors.initials: R
authors.lastname: Dorent
authors.forename: K
authors.initials: K
authors.lastname: Schwartz
authors.forename: M
authors.initials: M
authors.lastname: Komajda
mesh_terms: D000328:Adult; D000483:Alleles; D001120:Arginine; D002311:Cardiomyopathy, Dilated / Q000235:genetics*; D005069:Evaluation Studies as Topic; D005260:Female; D005815:Genetic Code; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005838:Genotype; D005998:Glycine; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D018342:Receptors, Adrenergic, beta-1 / Q000235:genetics*
chemical_list: D018342:Receptors, Adrenergic, beta-1; D001120:Arginine; D005998:Glycine